Sarsalejo, Lenelyn M.
HRN: 23-20-82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/26/2023
CEFUROXIME 500MG (TAB)
06/26/2023
07/03/2023
PO
500mg
BID X 7 Days
S/P NSVD; Leukocytosis
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes